Cholestanol storage disease: genes and variants
Explore variant evidence for Cholestanol storage disease across 1 analyzed protein (CYP27A1). Linked ClinVar records include 28 pathogenic or likely pathogenic variants, 262 variants of uncertain significance and 42 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Cholestanol storage disease
CYP27A1: Sterol 26-hydroxylase, mitochondrial
It hydroxylates sterol intermediates in bile-acid synthesis and contributes to cholesterol elimination and oxysterol production. Biallelic loss-of-function variants cause cerebrotendinous xanthomatosis, a treatable disorder with cholestanol accumulation, cataracts, tendon xanthomas, and progressive neurologic disease.
28 ClinVar pathogenic / likely pathogenic and 304 uncertain variants in CYP27A1 have source records linked to Cholestanol storage disease. Association strength is not clinical gene validity.
Where Cholestanol storage disease variants cluster
- CYP27A1 Sterol-binding (positions 384–398): 3 of 28 ClinVar pathogenic / likely pathogenic variants, 3.8× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Cholestanol storage disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CYP27A1 R395S | 395 | Sterol-binding | Pathogenic / likely pathogenic (★★) |
| CYP27A1 R395H | 395 | Sterol-binding | Pathogenic / likely pathogenic (★★) |
| CYP27A1 R395C | 395 | Sterol-binding | Pathogenic / likely pathogenic (★★) |
| CYP27A1 R474Q | 474 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R474W | 474 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R127Q | 127 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R127G | 127 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 A335V | 335 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R479C | 479 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 T339M | 339 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R405Q | 405 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R405W | 405 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 M130K | 130 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R137Q | 137 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 W268C | 268 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 A216P | 216 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 K259R | 259 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R513C | 513 | Pathogenic / likely pathogenic (★★) | |
| CYP27A1 R474P | 474 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 R479P | 479 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 R479S | 479 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 R479L | 479 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 R137P | 137 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 M1V | 1 | Pathogenic / likely pathogenic (★) | |
| CYP27A1 G145E | 145 | Pathogenic / likely pathogenic | |
| CYP27A1 P468S | 468 | Pathogenic / likely pathogenic | |
| CYP27A1 P401R | 401 | Pathogenic / likely pathogenic | |
| CYP27A1 D354G | 354 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Cholestanol storage disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CYP27A1 R137W | 137 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R137Q at the same position is pathogenic; REVEL 0.821 | |
| CYP27A1 M130T | 130 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; M130K at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.735 | |
| CYP27A1 M130I | 130 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; M130K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.72 |
Frequently asked questions
Which genes have records linked to Cholestanol storage disease?
This view contains 1 analyzed proteins: CYP27A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 28 pathogenic or likely pathogenic variants, 262 variants of uncertain significance and 42 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 396 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center